Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia
- PMID: 25908727
- PMCID: PMC4410164
- DOI: 10.1161/CIRCRESAHA.114.303517
Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia
Abstract
Lower extremity peripheral artery disease (PAD) is frequently underdiagnosed, in part because of the wide variety of leg symptoms manifested by patients with PAD and in part because of the high prevalence of asymptomatic PAD. In primary care medical practices, 30% to 60% of patients with PAD report no exertional leg symptoms and ≈45% to 50% report exertional leg symptoms that are not consistent with classic intermittent claudication. The prevalence and extent of functional impairment and functional decline in PAD may also be underappreciated. Functional impairment and functional decline are common in PAD, even among those who are asymptomatic. Lower extremity ischemia is also associated with pathophysiologic changes in calf skeletal muscle, including smaller calf muscle area, increased calf muscle fat content, impaired leg strength, and impaired metabolic function. People with severe PAD have poorer peroneal nerve conduction velocity compared with people with mild PAD or no PAD. The degree of ischemia-related pathophysiologic changes in lower extremity muscles and peripheral nerves of people with PAD are associated with the degree of functional impairment. New interventions are needed to improve functional performance and prevent mobility loss in the large number of patients with PAD, including in those who are asymptomatic or who have exertional leg symptoms other than claudication.
Keywords: intermittent claudication; peripheral arterial disease.
© 2015 American Heart Association, Inc.
Figures


Similar articles
-
Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review.JAMA. 2021 Jun 1;325(21):2188-2198. doi: 10.1001/jama.2021.2126. JAMA. 2021. PMID: 34061140 Review.
-
Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication.Circulation. 2008 May 13;117(19):2484-91. doi: 10.1161/CIRCULATIONAHA.107.736108. Epub 2008 May 5. Circulation. 2008. PMID: 18458172 Free PMC article.
-
Skeletal Muscle Pathology in Peripheral Artery Disease: A Brief Review.Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2577-2585. doi: 10.1161/ATVBAHA.120.313831. Epub 2020 Sep 17. Arterioscler Thromb Vasc Biol. 2020. PMID: 32938218 Free PMC article. Review.
-
Muscle strength and control characteristics are altered by peripheral artery disease.J Vasc Surg. 2017 Jul;66(1):178-186.e12. doi: 10.1016/j.jvs.2017.01.051. J Vasc Surg. 2017. PMID: 28647034 Free PMC article.
-
Preliminary evidence that low ankle-brachial index is associated with reduced bilateral hip extensor strength and functional mobility in peripheral arterial disease.J Vasc Surg. 2013 Apr;57(4):963-973.e1. doi: 10.1016/j.jvs.2012.08.103. Epub 2012 Dec 14. J Vasc Surg. 2013. PMID: 23246081 Clinical Trial.
Cited by
-
The effect of revascularization on recovery of mitochondrial respiration in peripheral artery disease: a case control study.J Transl Med. 2021 Jun 4;19(1):244. doi: 10.1186/s12967-021-02908-0. J Transl Med. 2021. PMID: 34088309 Free PMC article.
-
Clinical Assessment of Peripheral Arterial Disease in the Office: What Do the Guidelines Say?Semin Intervent Radiol. 2018 Dec;35(5):365-377. doi: 10.1055/s-0038-1676453. Epub 2019 Feb 5. Semin Intervent Radiol. 2018. PMID: 30728652 Free PMC article. Review.
-
Growth Hormone (GH) and Cardiovascular System.Int J Mol Sci. 2018 Jan 18;19(1):290. doi: 10.3390/ijms19010290. Int J Mol Sci. 2018. PMID: 29346331 Free PMC article. Review.
-
Disruption of mitochondrial quality control in peripheral artery disease: New therapeutic opportunities.Pharmacol Res. 2017 Jan;115:96-106. doi: 10.1016/j.phrs.2016.11.016. Epub 2016 Nov 19. Pharmacol Res. 2017. PMID: 27876411 Free PMC article. Review.
-
Joint Angle Variability Is Altered in Patients with Peripheral Artery Disease after Six Months of Exercise Intervention.Entropy (Basel). 2022 Oct 6;24(10):1422. doi: 10.3390/e24101422. Entropy (Basel). 2022. PMID: 37420442 Free PMC article.
References
-
- Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation. 2013;127:143–152. - PubMed
-
- Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–1340. - PubMed
-
- McDermott MM, Liu K, Criqui MH, Ruth K, Goff D, Saad MF, Wu C, Homma S, Sharrett AR. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2005;162:33–41. - PubMed
-
- Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463–e654. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical